Pharmaceutical formulations for the treatment of overactive bladder

Details for Australian Patent Application No. 2010201841 (hide)

Owner TheraVida, Inc.

Inventors Paborji, Mehdi; Tuohy lll, Robert V.; Freed, Peter R. P.; Flugel, Roger S.

Agent Spruson & Ferguson

Pub. Number AU-A-2010201841

Priority 61/320,202 01.04.10 US

Filing date 6 May 2010

Wipo publication date 20 October 2011

International Classifications

A61K 31/4178 (2006.01)

A61K 9/54 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

Event Publications

27 May 2010 Complete Application Filed

  Priority application(s): 61/320,202 01.04.10 US

20 October 2011 Application Open to Public Inspection

  Published as AU-A-2010201841

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010201842-Compositions and methods for detecting hepatitis B virus

2010201840-A closure assembly having a spout with a thicker band for spout directing